Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Talaris Therapeutics Says CEO Scott Requadt Will Be Leaving As Part Of Planned Workforce Reduction Announced Previously

Author: Benzinga Newsdesk | May 26, 2023 07:02am

Talaris has appointed Mary Kay Fenton as interim Chief Executive Officer and President effective as of today.

Posted In: TALS